Highbridge Capital Management »

Reneo Pharmaceuticals shares owned by Highbridge Capital Management

Quarter-by-quarter ownership of Reneo Pharmaceuticals (RPHM) shares owned by Highbridge Capital Management from 13F filings

Historical chart of Highbridge Capital Management investment in Reneo Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Reneo Pharmaceuticals held by Highbridge Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Reneo Pharmaceuticals by Highbridge Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $4.4M 2.9M 1.51
2024-03-31 $4.5B 2.7M 1660.00
2023-12-31 $1.8B 1.1M 1600.00

More positions owned by Highbridge Capital Management

Ishares Tr Option Put Option
Ford Mtr Co Del Bond (Principal)
Occidental Pete Corp Warrant (Principal) (OXY.WS)
Firstenergy Corp Bond (Principal)
American Airlines Group Bond (Principal)
Southern Bond (Principal)
Southwest Airls Bond (Principal)
Airbnb Bond (Principal)
Liberty Broadband Corp Common (LBRDK)
Hess Corp Common (HES)
Sarepta Therapeutics Bond (Principal)
Nice Bond (Principal)
Ventas Rlty Ltd Partnership Bond (Principal)
Dexcom Bond (Principal)
Guess Bond (Principal)

View all positions for Highbridge Capital Management

Top funds holding Reneo Pharmaceuticals

NEA Management Company
Tang Capital Management
Highbridge Capital Management
Carlyle
BML Capital Management
RiverVest Venture Management
Octagon Capital Advisors
Aisling Capital Management
Vanguard Group
Nantahala Capital Management
Vestal Point Capital
Aldebaran Capital
Renaissance Technologies
Acuitas Investments
BlackRock

View all funds holding Reneo Pharmaceuticals